Actionable news
0
All posts from Actionable news
Actionable news in EVOK: Evoke Pharma, Inc.,

What The Future Holds For Tonix

Summary

Tonix partially followed through on plans announced in April to sell shares to improve the company’s financial situation. It will need to sell more shares for its Phase III trials.

I introduce a framework for assessing the persuasiveness of various kinds of therapeutic outcome data, which I use to support the remaining assertions in this summary.

Although investors know Tonix’s PTSD trial missed its primary endpoint and that its findings were mostly positive, my secondary analysis of the data provides a substantially more upbeat...


More